Two Sigma Advisers’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-668,775
| Closed | -$26.5M | – | 2742 |
|
|
2024
Q1 | $26.5M | Buy |
668,775
+404,700
| +153% | +$16M | 0.06% | 285 |
|
|
2023
Q4 | $5.03M | Buy |
264,075
+18,000
| +7% | +$343K | 0.01% | 798 |
|
|
2023
Q3 | $2.82M | Buy |
246,075
+159,700
| +185% | +$1.83M | 0.01% | 1012 |
|
|
2023
Q2 | $888K | Buy |
86,375
+45,400
| +111% | +$467K | ﹤0.01% | 1582 |
|
|
2023
Q1 | $316K | Sell |
40,975
-24,200
| -37% | -$187K | ﹤0.01% | 2118 |
|
|
2022
Q4 | $479K | Sell |
65,175
-3,300
| -5% | -$24.3K | ﹤0.01% | 1895 |
|
|
2022
Q3 | $493K | Sell |
68,475
-33,100
| -33% | -$238K | ﹤0.01% | 1847 |
|
|
2022
Q2 | $864K | Sell |
101,575
-12,600
| -11% | -$107K | ﹤0.01% | 1672 |
|
|
2022
Q1 | $1.02M | Buy |
114,175
+6,400
| +6% | +$57.4K | ﹤0.01% | 1629 |
|
|
2021
Q4 | $1.49M | Buy |
107,775
+66,100
| +159% | +$916K | ﹤0.01% | 1335 |
|
|
2021
Q3 | $445K | Sell |
41,675
-27,500
| -40% | -$294K | ﹤0.01% | 1975 |
|
|
2021
Q2 | $623K | Sell |
69,175
-56,800
| -45% | -$512K | ﹤0.01% | 1845 |
|
|
2021
Q1 | $1.34M | Buy |
125,975
+23,200
| +23% | +$246K | ﹤0.01% | 1485 |
|
|
2020
Q4 | $1.3M | Buy |
102,775
+29,300
| +40% | +$369K | ﹤0.01% | 1454 |
|
|
2020
Q3 | $646K | Buy |
+73,475
| New | +$646K | ﹤0.01% | 1703 |
|